The Food and Drug Administration on Thursday classified the voluntary recall of certain respiratory masks made by ResMed as “most serious” as their incorrect use could cause major injuries or death.
As competitor Philips continues to grapple with the effects of its long-standing recall of continuous positive airway pressure (CPAP) machines and other respiratory devices, ResMed is now issuing a ...
ResMed (NYSE:RMD) has issued an urgent safety notice for masks used with continuous positive airway pressure, or CPAP, machines over concerns that magnets contained in the masks may interfere with ...
ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.
SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about potential ...
Please provide your email address to receive an email when new articles are posted on . ResMed CPAP masks that contain magnets are being recalled due to possible magnetic interference with medical ...
ResMed RMD continues to see growth in patient diagnosis trends in sleep apnea, COPD and asthma. Yet, we are worried about the stiff competition faced by ResMed. The stock carries a Zacks Rank #3 (Hold ...
ResMed focuses on developing medical devices to treat sleep apnoea and other respiratory problems, and on educating caregivers about therapy options. The firm's product portfolio consists of airflow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback